BioSenic dépose une demande de protection supplémentaire par brevet, suite à de nouvelles preuves cliniques de l'efficacité de JTA-004 dans le traitement de l'arthrose
23 janv. 2024 01h00 HE
|
BioSenic
COMMUNIQUE DE PRESSE – INFORMATION PRIVILEGIEE À la suite d'une analyse post hoc d'un essai de phase 3 démontrant un soulagement de la douleur chez les patients souffrant d'arthrose sévère du...
BioSenic files for additional patent protection following new clinical evidence of efficacy for JTA-004 in osteoarthritis
23 janv. 2024 01h00 HE
|
BioSenic
PRESS RELEASE – INSIDE INFORMATION Following a post-hoc analysis of a Phase 3 trial demonstrating pain relief in patients with severe knee osteoarthritis, Biosenic applied for an international...
Kane Biotech Announces Special Meeting of Shareholders
18 janv. 2024 16h30 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces today that on February 20, 2024, the Company will...
Digital Science announces IFI CLAIMS annual rankings: Samsung leads again in U.S. patents while Qualcomm leaps into second place; overall grants dip 3.4%
09 janv. 2024 04h00 HE
|
Digital Science
New 2023 patent data rankings highlight escalating areas of R&D activity, according to an annual patent study by Digital Science company IFI CLAIMS.
Tiziana Life Sciences Files New Patent Application for Combination Therapy of anti-CD3 (Foralumab) with GLP-1 Receptor Agonist for Additional Reduction of Obesity - Associated Inflammation
05 janv. 2024 07h00 HE
|
Tiziana Life Sciences Ltd.
Tiziana Life Sciences Files New Patent Application for Combination Therapy of anti-CD3 (Foralumab) with GLP-1 Receptor Agonist
Valyant Enters into Settlement Agreement with Hi Auto and kea to Resolve Patent Litigation
27 déc. 2023 08h00 HE
|
Valyant AI
Denver, Colo., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Valyant AI, Hi Auto, and kea have entered into a settlement agreement to resolve their pending litigation related to Valyant’s patents for voice...
Sunrise New Energy Secures Highly Regarded Japanese Patent for Invention of Lithium-Ion Battery Anode Material Preparation Method
21 déc. 2023 09h25 HE
|
Sunrise New Energy Co., Ltd
ZIBO, China, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Sunrise New Energy Co., Ltd. (“Sunrise”, the “Company”, “we” or “our”) (NASDAQ: EPOW), today announced that its patent application for the invention...
Sunrise New Energy Announces Patent Application for Multivariable Particle Size Control System for Graphite Micropowder Production Accepted by the National Intellectual Property Bureau
18 déc. 2023 09h25 HE
|
Sunrise New Energy Co., Ltd
ZIBO, China, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Sunrise New Energy Co., Ltd. (“Sunrise”, the “Company”, “we” or “our”) (NASDAQ: EPOW), today announced that the patent application for the invention...
Positive opinion from ISA-Israel patent office Provides the ability to file a patent application under the Patent Prosecution Highway (PPH) in the US
18 déc. 2023 08h30 HE
|
BYND Cannasoft Enterprises, Inc.
ASHKELON, Israel and VANCOUVER, British Columbia, Dec. 18, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") announced today a...
Wearable Devices Sets New Standard in AR/VR Era with U.S Patent Application for Innovative Touchless Technology
18 déc. 2023 08h00 HE
|
Wearable Devices Ltd.
The Company filed a U.S patent application for its new touchless pinch-to-zoom technology YOKNEAM ILLIT, ISRAEL, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the “Company” or...